VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody ; volume:40 ; number:1 ; day:14 ; month:10 ; year:2021 ; pages:1-19 ; date:12.2021
Journal of experimental & clinical cancer research ; 40, Heft 1 (14.10.2021), 1-19, 12.2021
- Creator
-
Micheli, Laura
Parisio, Carmen
Lucarini, Elena
Vona, Alessia
Toti, Alessandra
Pacini, Alessandra
Mello, Tommaso
Boccella, Serena
Ricciardi, Flavia
Maione, Sabatino
Graziani, Grazia
Lacal, Pedro Miguel
Failli, Paola
Ghelardini, Carla
Di Cesare Mannelli, Lorenzo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-021-02127-x
- URN
-
urn:nbn:de:101:1-2021122819013277081614
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Micheli, Laura
- Parisio, Carmen
- Lucarini, Elena
- Vona, Alessia
- Toti, Alessandra
- Pacini, Alessandra
- Mello, Tommaso
- Boccella, Serena
- Ricciardi, Flavia
- Maione, Sabatino
- Graziani, Grazia
- Lacal, Pedro Miguel
- Failli, Paola
- Ghelardini, Carla
- Di Cesare Mannelli, Lorenzo
- SpringerLink (Online service)
Other Objects (12)
Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Veränderung der Expression von VEGF, VEGFR-1, VEGFR-2, MMP12 und Rab23 in der Lunge von Patienten mit parenchymatösen Lungenerkrankungen
Der differentielle Einfluss der beiden VEGF-Rezeptoren VEGFR-1 und VEGFR-2 auf die Genexpression von PIGF und MCP-1
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
Molecular structure‐function relationship of dietary polyphenols for inhibiting VEGF‐induced VEGFR‐2 activity
Der Einfluss von Neuropilin-2 auf die VEGF- und die VEGFR-Expression beim uvealen Melanom
Effekte der Wachstumsfaktoren VEGF-C und VEGF-D und Signaltransduktion des Rezeptors VEGFR-3 in Zellen des zentralen Nervensystems
Mechanical Forces Induce Changes in VEGF and VEGFR-1/sFlt-1 Expression in Human Chondrocytes
Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Veränderung der Expression von VEGF, VEGFR-1, VEGFR-2, MMP12 und Rab23 in der Lunge von Patienten mit parenchymatösen Lungenerkrankungen
Der differentielle Einfluss der beiden VEGF-Rezeptoren VEGFR-1 und VEGFR-2 auf die Genexpression von PIGF und MCP-1
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
Molecular structure‐function relationship of dietary polyphenols for inhibiting VEGF‐induced VEGFR‐2 activity
Der Einfluss von Neuropilin-2 auf die VEGF- und die VEGFR-Expression beim uvealen Melanom
Effekte der Wachstumsfaktoren VEGF-C und VEGF-D und Signaltransduktion des Rezeptors VEGFR-3 in Zellen des zentralen Nervensystems
Mechanical Forces Induce Changes in VEGF and VEGFR-1/sFlt-1 Expression in Human Chondrocytes
Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Veränderung der Expression von VEGF, VEGFR-1, VEGFR-2, MMP12 und Rab23 in der Lunge von Patienten mit parenchymatösen Lungenerkrankungen
Der differentielle Einfluss der beiden VEGF-Rezeptoren VEGFR-1 und VEGFR-2 auf die Genexpression von PIGF und MCP-1
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
Molecular structure‐function relationship of dietary polyphenols for inhibiting VEGF‐induced VEGFR‐2 activity
Der Einfluss von Neuropilin-2 auf die VEGF- und die VEGFR-Expression beim uvealen Melanom
Effekte der Wachstumsfaktoren VEGF-C und VEGF-D und Signaltransduktion des Rezeptors VEGFR-3 in Zellen des zentralen Nervensystems